🟢 Tscan Therapeutics is trading 5% up today amid broader risk-on sentiment

Tscan Therapeutics is trading 5.17% up at $0.34, continuing its rebound after reaching $0.31 on September 14.

• The stock is recovering from the September 8 close of $0.34.
• No fresh company-specific announcement was identified for September 16; the latest major update was the September 2 strategic reorganization.
• The Nasdaq gained 0.59%, while biotech overall is weaker; broader risk-on sentiment may be supporting the move.